Literature DB >> 25606363

Fragile X spectrum disorders.

Reymundo Lozano1, Carolina Alba Rosero2, Randi J Hagerman1.   

Abstract

The fragile X mental retardation 1 gene (FMR1), which codes for the fragile X mental retardation 1 protein (FMRP), is located at Xp27.3. The normal allele of the FMR1 gene typically has 5 to 40 CGG repeats in the 5' untranslated region; abnormal alleles of dynamic mutations include the full mutation (> 200 CGG repeats), premutation (55-200 CGG repeats) and the gray zone mutation (45-54 CGG repeats). Premutation carriers are common in the general population with approximately 1 in 130-250 females and 1 in 250-810 males, whereas the full mutation and Fragile X syndrome (FXS) occur in approximately 1 in 4000 to 1 in 7000. FMR1 mutations account for a variety of phenotypes including the most common monogenetic cause of inherited intellectual disability (ID) and autism (FXS), the most common genetic form of ovarian failure, the fragile X-associated primary ovarian insufficiency (FXPOI, premutation); and fragile X-associated tremor/ataxia syndrome (FXTAS, premutation). The premutation can also cause developmental problems including ASD and ADHD especially in boys and psychopathology including anxiety and depression in children and adults. Some premutation carriers can have a deficit of FMRP and some unmethylated full mutation individuals can have elevated FMR1 mRNA that is considered a premutation problem. Therefore the term "Fragile X Spectrum Disorder" (FXSD) should be used to include the wide range of overlapping phenotypes observed in affected individuals with FMR1 mutations. In this review we focus on the phenotypes and genotypes of children with FXSD.

Entities:  

Keywords:  Fragile X syndrome; autism spectrum disorder; developmental delay; intellectual disability; premutation

Year:  2014        PMID: 25606363      PMCID: PMC4298643          DOI: 10.5582/irdr.2014.01022

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  157 in total

Review 1.  FMR1 and the continuum of primary ovarian insufficiency.

Authors:  Shannon D Sullivan; Corrine Welt; Stephanie Sherman
Journal:  Semin Reprod Med       Date:  2011-10-03       Impact factor: 1.303

2.  Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation.

Authors:  Faraz Farzin; Hazel Perry; David Hessl; Danuta Loesch; Jonathan Cohen; Susan Bacalman; Louise Gane; Flora Tassone; Paul Hagerman; Randi Hagerman
Journal:  J Dev Behav Pediatr       Date:  2006-04       Impact factor: 2.225

3.  FMRP expression as a potential prognostic indicator in fragile X syndrome.

Authors:  F Tassone; R J Hagerman; D N Iklé; P N Dyer; M Lampe; R Willemsen; B A Oostra; A K Taylor
Journal:  Am J Med Genet       Date:  1999-05-28

4.  Association of FMR1 repeat size with ovarian dysfunction.

Authors:  A K Sullivan; M Marcus; M P Epstein; E G Allen; A E Anido; J J Paquin; M Yadav-Shah; S L Sherman
Journal:  Hum Reprod       Date:  2004-12-17       Impact factor: 6.918

5.  Defining genetically meaningful language and personality traits in relatives of individuals with fragile X syndrome and relatives of individuals with autism.

Authors:  Molly Losh; Jessica Klusek; Gary E Martin; John Sideris; Morgan Parlier; Joseph Piven
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-06-12       Impact factor: 3.568

6.  Expanded clinical phenotype of women with the FMR1 premutation.

Authors:  Sarah M Coffey; Kylee Cook; Nicole Tartaglia; Flora Tassone; Danh V Nguyen; Ruiqin Pan; Hannah E Bronsky; Jennifer Yuhas; Mariya Borodyanskaya; Jim Grigsby; Melanie Doerflinger; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2008-04-15       Impact factor: 2.802

7.  FMR1 protein: conserved RNP family domains and selective RNA binding.

Authors:  C T Ashley; K D Wilkinson; D Reines; S T Warren
Journal:  Science       Date:  1993-10-22       Impact factor: 47.728

Review 8.  Phenotypic variation and FMRP levels in fragile X.

Authors:  Danuta Z Loesch; Richard M Huggins; Randi J Hagerman
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2004

9.  Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome.

Authors:  Peng Jin; Ranhui Duan; Abrar Qurashi; Yunlong Qin; Donghua Tian; Tracie C Rosser; Huijie Liu; Yue Feng; Stephen T Warren
Journal:  Neuron       Date:  2007-08-16       Impact factor: 17.173

10.  Histone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndrome.

Authors:  Peter K Todd; Seok Yoon Oh; Amy Krans; Udai B Pandey; Nicholas A Di Prospero; Kyung-Tai Min; J Paul Taylor; Henry L Paulson
Journal:  PLoS Genet       Date:  2010-12-09       Impact factor: 5.917

View more
  63 in total

Review 1.  Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder.

Authors:  Reymundo Lozano; Veronica Martinez-Cerdeno; Randi J Hagerman
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 2.  Advanced technologies for the molecular diagnosis of fragile X syndrome.

Authors:  Flora Tassone
Journal:  Expert Rev Mol Diagn       Date:  2015-10-21       Impact factor: 5.225

Review 3.  A general description for Chinese medicine in treating premature ovarian failure.

Authors:  Jing Lin; Xue-Lian Li; Hui Song; Qian Li; Ming-Yan Wang; Xue-Min Qiu; Da-Jin Li; Ling Wang
Journal:  Chin J Integr Med       Date:  2017-03-07       Impact factor: 1.978

Review 4.  Molecular Pathophysiology of Fragile X-Associated Tremor/Ataxia Syndrome and Perspectives for Drug Development.

Authors:  Teresa Botta-Orfila; Gian Gaetano Tartaglia; Aubin Michalon
Journal:  Cerebellum       Date:  2016-10       Impact factor: 3.847

5.  Impact of autism-associated genetic variants in interaction with environmental factors on ADHD comorbidities: an exploratory pilot study.

Authors:  Regina Waltes; Christine M Freitag; Timo Herlt; Thomas Lempp; Christiane Seitz; Haukur Palmason; Jobst Meyer; Andreas G Chiocchetti
Journal:  J Neural Transm (Vienna)       Date:  2019-11-09       Impact factor: 3.575

6.  Gene-set analysis shows association between FMRP targets and autism spectrum disorder.

Authors:  Arija Jansen; Gwen C Dieleman; August B Smit; Matthijs Verhage; Frank C Verhulst; Tinca J C Polderman; Danielle Posthuma
Journal:  Eur J Hum Genet       Date:  2017-04-19       Impact factor: 4.246

7.  The Number of Parvalbumin-Expressing Interneurons Is Decreased in the Prefrontal Cortex in Autism.

Authors:  Ezzat Hashemi; Jeanelle Ariza; Haille Rogers; Stephen C Noctor; Verónica Martínez-Cerdeño
Journal:  Cereb Cortex       Date:  2017-03-01       Impact factor: 5.357

Review 8.  Altered Neuronal and Circuit Excitability in Fragile X Syndrome.

Authors:  Anis Contractor; Vitaly A Klyachko; Carlos Portera-Cailliau
Journal:  Neuron       Date:  2015-08-19       Impact factor: 17.173

9.  Double-strand break repair plays a role in repeat instability in a fragile X mouse model.

Authors:  Inbal Gazy; Bruce Hayward; Svetlana Potapova; Xiaonan Zhao; Karen Usdin
Journal:  DNA Repair (Amst)       Date:  2018-12-21

Review 10.  Recent advances in assays for the fragile X-related disorders.

Authors:  Bruce E Hayward; Daman Kumari; Karen Usdin
Journal:  Hum Genet       Date:  2017-09-02       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.